SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurogen (NRGN)
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
523 35 0 NRGN
Emcee:  Terry McCormick Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
498stock is flat..odd..mopgcw-1/8/2008
497DOUBLE OUCH. Owned this sucker for forever, as I respect their attitude toward scaram(o)uche-1/8/2008
496OUCH. I bought a chunk to trade at the lows, but looks like I will hold on to imopgcw-1/8/2008
495Neurogen halts obesity testing, hopes to outlicense MCH prpogram, but . . tuck-1/7/2008
494<i>Adipiplon couldn't they come up with a better name?</i> WithBiomaven-11/29/2007
493As far as VR1, that's the downside to partnering early with pfe or mrk, it srkrw-11/12/2007
492Ah hah . . . Merck is going to back-up compound for pain, while keeping MKtuck-11/12/2007
491NG@-73 at Neuroscience 2007: >>Program#/Poster#: 632.2/AAA17 Title: IIItuck-11/6/2007
490That was quick. it took me two days to get filled...mopgcw-10/31/2007
489Got filled. I guess I should be happy, as the stock just bounced nicely, and mytuck-10/30/2007
488The all time intraday low for NRGN was $3.42 on January 22nd, 2003. I have a lotuck-10/30/2007
487i too added another slug here at 3.75...mopgcw-10/24/2007
486Thanks, yes, 2295 is 8243. Proof of concept P2 started almost a year ago. I wotuck-10/18/2007
485VR1: The Merck pipeline chart lists MK-2295 as a "Proof of Concept Molecultommysdad-10/18/2007
484Another chance to average down. I bailed my position a few weeks ago for a modetuck-10/18/2007
483From CIBC <b>Highlights From Neurogen's Insomnia Focused Panel Discusidos-9/26/2007
482>>Neurogen Corporation Announces Second Quarter 2007 Financial Results Thutuck-8/2/2007
481great price. i am in at 5, and want to average down here, unfortunately, i thinmopgcw-7/31/2007
480Short interest went from a few hundred thousand to 2.4 million last month. I jutuck-7/31/2007
479not to be contrary, but this is not surprising for this stock, the volatility hamopgcw-7/26/2007
478The sleep program sounds like indiplon redux to me and only 7 years behind. Pkeokalani'nui-7/26/2007
477Funny you should mention it . . . I just got back in for $4.90. The onltuck-7/26/2007
476Ugly little price drop in nrgn. ~50% in 6 weeks without a publicly announced drkeokalani'nui-7/26/2007
475>>Neurogen Announces Results of First-in-Human Trial for New Approach to Ttuck-6/25/2007
474So. I see I am a disaster. The last time I updated my nrgn notes was january akeokalani'nui-6/25/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News